Journal News

Proteomics reveals hallmarks of aging in brain stem cells

Laurel Oldach
July 9, 2020

Myelin, a fatty substance akin to wire insulation, allows fast neuronal signaling both within the brain and to the rest of the body. When myelin in the brain or spinal cord is damaged, adult stem cells called oligodendrocyte progenitor cells, or OPCs, respond by developing into new, fully fledged oligodendrocytes that wrap new myelin around neurons, protecting them and restoring their ability to carry fast electrical messages.

OPCs-445x445.jpg
Alerie Guzman de la Fuente
A cell culture mixture grown in the lab includes oligodendrocyte progenitor cells (green dots) and differentiated oligodendrocytes (white and red, with branches). Guzman de la Fuente conducted the cell culture and microscopy.

The human body’s ability to regenerate lost myelin declines with age. Patients with multiple sclerosis are intimately familiar with this shift. The disease, usually diagnosed in a patient’s twenties, arises when a person develops an immune response to myelin proteins. It starts out as a series of flare-ups of symptoms such as muscle weakness and numbness, followed by months or even years in remission as new oligodendrocytes provide fresh myelin. The disease shifts to a progressively worsening disability in middle age.

Neuroscientist Alerie Guzman de la Fuente is interested in developing a better understanding of oligodendrocyte progenitor cells to determine why remyelination falters with age. The answer could inform scientists who hope someday to treat MS with pro-remyelinating therapies.

“Most labs studying oligodendrocyte progenitor biology use neonatal OPCs to test drugs,” Guzman de la Fuente said. “These cells are incredibly powerful at forming myelin.” That makes them an imperfect system for studying how myelin formation goes awry with age, she said. “We think that studying adult OPCs … is more relevant to what will happen in the progressive phases of MS, in patients over 50.”

In a recent paper in the journal Molecular & Cellular Proteomics, Guzman de la Fuente and her colleagues in Robin Franklin’s lab at the University of Cambridge reported a comparison of the proteomes of OPCs from neonatal, young adult and mature mice. Franklin’s lab and others previously have studied the transcriptome of these cells. However, Guzman de la Fuente emphasized, RNA and protein levels are not always perfectly correlated.

Some protein features were quite stable through a mouse’s lifetime. Others changed dramatically. The team focused on the proteins that changed most between young and mature adulthood, and they identified a few patterns.

As with many aging cells, the stem cells from older mice showed some gene-expression drift, acting as if they had begun to differentiate but without gaining the ability to make myelin. The team noticed that as animals aged, their stem cells were more likely to have difficulty metabolizing cholesterol, an important component of myelin; older OPCs were more apt to express proteins involved in other neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease, although what these changes mean remains to be elucidated . Finally, as with many aging cells, the OPCs from older mice also showed changes in protein homeostasis.

It will take time and further experiments to determine which of these changes cause the remyelination decline that appears with age. But, Guzman de la Fuente said, having a clearer picture of how the brain changes with aging can only help future efforts to treat multiple sclerosis.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Laurel Oldach

Laurel Oldach is a former science writer for the ASBMB.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

From the Journals: JBC
Journal News

From the Journals: JBC

March 25, 2025

How cells recover from stress. Cancer cells need cysteine to proliferate. Method to make small membrane proteins. Read about papers on these topics recently published in the Journal of Biological Chemistry.

ASBMB names 2025 JBC/Tabor Award winners
Award

ASBMB names 2025 JBC/Tabor Award winners

March 24, 2025

The six awardees are first authors of outstanding papers published in 2024 in the Journal of Biological Chemistry.

Pan-kinase inhibitor for head and neck cancer enters clinical trials
Journal News

Pan-kinase inhibitor for head and neck cancer enters clinical trials

March 18, 2025

A drug targeting the scaffolding function of multiple related kinases halts tumor progression.

Sweet secrets of sperm glycosylation
Journal News

Sweet secrets of sperm glycosylation

March 12, 2025

Scientists from Utrecht University uncover similar glycosylation patterns in sperm from bulls, boars and humans, distinct from those found in blood across species. These findings may improve IVF and farming techniques.

From the Journals: JLR
Journal News

From the Journals: JLR

March 11, 2025

Promising therapeutic candidate for steatosis. Unique lipid profiles in glycogen storage disease. Microglial lactic acid mediates neuroinflammation. Read about these recent papers.

Meet Robert Helsley
Interview

Meet Robert Helsley

March 6, 2025

The Journal of Lipid Research junior associate editor studies chronic liver disease and was the first in his family to attend college.